Orşiektomi Yapılan Sedasyonlu Köpeklerde Epidural Deksmedetomidinin Fizibilite, Reverzibilite ve Kardiyorespiratuvar Etkilerinin Değerlendirilmesi
Bu çalışmanın amacı; orşiektomi yapılan sedasyonlu köpeklerde epidural deksmedetomidinin (DEX) geri dönüşlü sedasyon ve kardiyorespiratuvar değişiklikleri ile yeterli anti-nosisepsiyon üretip üretmediğini değerlendirmekti. Çalışmada ortalama ağıtlıkları 21.7±5.2 kg olan on iki erkek köpek kullanıldı. Köpeklere intramüsküler yolla asepromazin (0.025 mg/kg) ve morfin (0.25 mg/kg) ardından intravenöz yolla (IV) ikinci bir doz morfin (0.125 mg/kg) uygulandı. Tüm köpeklere (n=12) epidural yolla DEX (3 µg/kg) uygulandı. Prescrotal bölgenin tam duyusal blokajı sağlandıktan sonra orşiektomi operasyonu yapıldı. Ameliyat sırasında herhangi bir rahatsızlık tespit edilirse, ağrılı bölgeye 2-3 mL %1’lik lidokain (en fazla iki kez) uygulandı. Epidural uygulamadan altmış dakika sonra, köpekler IV atipamezol (ATP; n=6) veya salin (SAL; n=6) tedavisi alacak şekilde rastgele gruplandırıldı. Köpeklerin hiçbirinde genel anestezi uygulanması gerekmedi; ancak, on iki köpekten dokuzuna lidokain uygulandı. ATP'de duyusal blokajın süresi, SAL'dan daha kısaydı. Kalp atış hızı, solunum hızı ve rektal sıcaklık, DEX uygulamasından sonraki ölçümler ile karşılaştırıldığında önemli ölçüde düşüş gösterdi. Atipamezol uygulaması, sedasyon, duyusal blokaj ve kardiyorespiratuvar değişiklikleri tersine çevirdi. Sonuç olarak, epidural DEX, sedasyon uygulanan köpeklerde orşiektomi sırasında yeterli anti-nosisepsiyon etki üretmediği belirlendi. Epidural DEX'in neden olduğu sedasyon, duyusal blokaj ve kardiyorespiratuvar değişiklikler IV atipamezol uygulamasıyla tersine çevrilebilir.
Evaluation of the Feasibility, Reversibility and Cardiorespiratory Effcts of Epidural Dexmedetomidine in Sedated Dogs Undergoing Orchiectomy
The objective of the present study was to evaluate whether epidural dexmedetomidine (DEX) produces sufficient anti-nociception withreversible sedation and cardiorespiratory changes in sedated dogs undergoing orchiectomy. Twelve male dogs weighing 21.7±5.2 kg wereused. Dogs received acepromazine (0.025 mg/kg) and morphine (0.25 mg/kg) intramuscularly and a second dose of morphine (0.125 mg/kg)intravenously (IV). DEX (3 µg/kg) was administered epidurally to all dogs (n=12). After confirming complete sensory blockade of the prescrotalregion, orchiectomy was performed. If any discomfort was detected during surgery, 2-3 mL lidocaine 1% (maximum two times) was appliedinto the painful area. Sixty minutes after epidural application, dogs were randomly assigned to receive either treatment of atipamezole(ATP; n=6) or saline (SAL; n=6) IV. None of the dogs required general anesthesia; however, nine out of twelve dogs received lidocaine. Theduration of sensory blockade was significantly shorter in ATP than that of SAL. Heart rate, respiratory rate, and rectal temperature showedsignificantly lower values compared with base after administration of DEX. Administration of atipamezole reversed sedation, sensory blockadeand cardiorespiratory changes. In conclusion, epidural DEX did not produce adequate anti-nociception during orchiectomy in sedated dogs.Sedation, sensory blockade and cardiorespiratory changes induced by epidural DEX can be reversed by IV administration of atipamezole.
___
- 1. Lorena SE, Luna SP, Lascelles BDX, Corrente JE: Current attitudes
regarding the use of perioperative analgesics in dogs and cats by Brazilian
veterinarians. Vet Anaesth Analg, 41 (1): 82-89, 2014. DOI: 10.1111/vaa.12104
- 2. Nickell J, Barter LS, Dechant JE: Effcts of intratesticular and incisional
local anesthetic administration for castration of alpacas anesthetized
with intramuscular ketamine-xylazine-butorphanol. Vet Surg, 44 (2): 168-
173, 2015. DOI: 10.1111/j.1532-950X.2014.12285.x
- 3. Park SJ, Piao M, Kim H, Kang HJ, Seo J, Lee S, Baik M: Effects
of castration and a lidocaine-plus-flnixin treatment on growth and
indicators of pain, inflmmation, and liver function in Korean cattle bull
calves. Livest Sci, 216, 61-66, 2018. DOI: 10.1016/j.livsci.2018.07.010
- 4. Racine J, Vidondo B, Ramseyer A, Koch C: Complications associated
with closed castration using the H enderson equine castration instrument
in 300 standing equids. Vet Surg, 48 (1): 21-28, 2019. DOI: 10.1111/
vsu.12960
- 5. Campoy L, Martin-Flores M, Ludders JW, Gleed RD: Procedural
sedation combined with locoregional anesthesia for orthopedic surgery
of the pelvic limb in 10 dogs: Case series. Vet Anaesth Analg, 39 (4): 436-
440, 2012. DOI: 10.1111/j.1467-2995.2012.00712.x
- 6. Kushnir Y, Toledano N, Cohen L, Bdolah-Abram T, Shilo-Benjamini
Y: Intratesticular and incisional line infiltration with ropivacaine for
castration in medetomidine-butorphanol-midazolam sedated dogs. Vet
Anaesth Analg, 44 (2): 346-355, 2017. DOI: 10.1016/j.vaa.2016.03.007
- 7. Yayla S, Kaçar C, Kılıç E, Kaya S, Kuru M, Ermutlu CŞ, Özaydın İ,
Hüseyinoğlu Ü, Öğün M: The effcts of intrathecal administration of
bupivacaine or ropivacaine following administration of propofol in dogs
undergoing ovariohysterectomy. Kafkas Univ Vet Fak Derg, 23 (3): 363-367,
2017. DOI: 10.9775/kvfd.2016.16665
- 8. Campoy L, Read M, Peralta S: Canine and Feline Local Anesthetic and
Analgesic Techniques. In, Grimm KA, Lamont LA, Tranquilli WJ, Greene
SA, Robertson SA (Eds): Veterinary Anesthesia and Analgesia, The Fifth
Edition of Lumb and Jones., 827-856, John Wiley & Sons, Pondicherry,
India, 2015.
- 9. Jones RS: Epidural analgesia in the dog and cat. Vet J, 161 (2): 123-131,
2001. DOI: 10.1053/tvjl.2000.0528
- 10. Steagall PVM, Simon BT, Teixeira Neto FJ, Luna SPL: An update on
drugs used for lumbosacral epidural anesthesia and analgesia in dogs.
Front Vet Sci, 4:68, 2017. DOI: 10.3389/fvets.2017.00068
- 11. Kuusela E, Raekallio M, Anttila M, Falck I, Molsa S, Vainio O: Clinical
effcts and pharmacokinetics of medetomidine and its enantiomers
in dogs. J Vet Pharmacol Ther, 23 (1): 15-20, 2000. DOI: 10.1046/j.1365-
2885.2000.00245.x
- 12. Bennett RC, Restitutti F: Dexmedetomidine or medetomidine:
Which should veterinary surgeons select? Companion Anim, 21 (3): 128-
137, 2016. DOI: 10.12968/coan.2016.21.3.128
- 13. Bloor BC, Frankland M, Alper G, Raybould D, Weitz J, Shurtlif
M: Hemodynamic and sedative effects of dexmedetomidine in dog. J
Pharmacol Exp Ther, 263 (2): 690-697, 1992.
- 14. Pascoe PJ, Raekallio M, Kuusela E, McKusick B, Granholm M:
Changes in the minimum alveolar concentration of isoflrane and some
cardiopulmonary measurements during three continuous infusion rates
of dexmedetomidine in dogs. Vet Anaesth Analg, 33 (2): 97-103, 2006. DOI:
10.1111/j.1467-2995.2005.00236.x
- 15. Smith CK, Seddighi R, Cox SK, Sun X, Knych HK, Doherty TJ:
Effct of dexmedetomidine on the minimum infusion rate of propofol
preventing movement in dogs. Vet Anaesth Analg, 44 (6): 1287-1295,
2017. DOI: 10.1016/j.vaa.2017.07.004
- 16. Vasiljević M, Krstić V, Stanković S, Zrimšek P, Svete AN, Seliškar
A: Cardiac troponin I in dogs anaesthetized with propofol and
sevoflrane: The Inflence of medetomidine premedication and inspired
oxygen fraction. Vet Anaesth Analg, 45 (6): 745-753, 2018. DOI: 10.1016/j.
vaa.2018.07.003
- 17. Campagnol D, Neto FJT, Giordano T, Ferreira TH, Monteiro ER:
Effcts of epidural administration of dexmedetomidine on the minimum
alveolar concentration of isoflrane in dogs. Am J Vet Res, 68 (12): 1308-
1318, 2007. DOI: 10.2460/ajvr.68.12.1308
- 18. Rector E, Kramer S, Kietzmann M, Hart S, Nolte I: Evaluation of
the antinociceptive effct of systemic and epidurally applied xylazine in
general anesthesia with isoflrane in dogs and the effct of atipamezole
infection on postoperative analgesia. Berl Munch Tierarztl Wochenschr,
111 (11-12): 438-451, 1998.
- 19. Lee I, Yamagishi N, Oboshi K, Yamada H: Antagonistic effcts of
intravenous or epidural atipamezole on xylazine-induced dorsolumbar
epidural analgesia in cattle. Vet J, 166 (2): 194-197, 2003. DOI: 10.1016/
S1090-0233(03)00026-1
- 20. Sullivan AF, Kalso EA, McQuay HJ, Dickenson AH: The antinociceptive actions of dexmedetomidine on dorsal horn neuronal
responses in the anaesthetized rat. Eur J Pharmacol, 215 (1): 127-133,
1992. DOI: 10.1016/0014-2999(92)90617-D
- 21. Sullivan AF, Dashwood MR, Dickenson AH: α2-adrenoceptor
modulation of nociception in rat spinal cord: Location, effects and
interactions with morphine. Eur J Pharmacol, 138 (2): 169-177, 1987. DOI:
10.1016/0014-2999(87)90430-4
- 22. Sabbe MB, Penning JP, Ozaki GT, Yaksh TL: Spinal and systemic
action of the alpha 2 receptor agonist dexmedetomidine in dogs.
Antinociception and carbon dioxide response. Anesthesiology, 80 (5):
1057-1072, 1994.
- 23. Pohl VH, Carregaro AB, Lopes C, Gehrcke MI, Muller D, Garlet CD:
Epidural anesthesia and postoperatory analgesia with alpha-2 adrenergic
agonists and lidocaine for ovariohysterectomy in bitches. Can J Vet Res, 76
(3): 215-220, 2012.
- 24. Nishimura LT, Auckburally A, Santilli J, Vieira BHB, Garcia DO,
Honsho CS, de Mattos-Junior E: Effcts of dexmedetomidine combined
with commonly administered opioids on clinical variables in dogs. Am J
Vet Res, 79 (3): 267-275, 2018. DOI: 10.2460/ajvr.79.3.267
- 25. Raillard M, Michaut-Castrillo J, Spreux D, Gauthier O, TouzotJourde G, Holopherne-Doran D: Comparison of medetomidine-morphine
and medetomidine-methadone for sedation, isoflrane requirement and
postoperative analgesia in dogs undergoing laparoscopy. Vet Anaesth
Analg, 44 (1): 17-27, 2017. DOI: 10.1111/vaa.12394
- 26. Murrell JC, Hellebrekers LJ: Medetomidine and dexmedetomidine:
A review of cardiovascular effcts and antinociceptive properties in the
dog. Vet Anaesth Analg, 32 (3): 117-127, 2005. DOI: 10.1111/j.1467-2995.
2005.00233.x
- 27. Maze M, Tranquilli W: Alpha-2 adrenoceptor agonists: Defining the
role in clinical anesthesia. Anesthesiology, 74, 581-605, 1991.
- 28. Ko JCH, Fox SM, Mandsager RE: Sedative and cardiorespiratory
effcts of medetomidine, medetomidine-butorphanol, and medetomidineketamine in dogs. J Am Vet Med Assoc, 216 (10): 1578-1583, 2000. DOI:10.2460/javma.2000.216.1578
- 29. Kuusela E, Vainio O, Short CE, Leppäluoto J, Huttunen P, Ström
S, Huju V, Valtonen A, Raekallio M: A comparison of propofol infusion
and propofol/isoflrane anaesthesia in dexmedetomidine premedicated
dogs. J Vet Pharmacol Ther, 26 (3): 199-204, 2003. DOI: 10.1046/j.1365-
2885.2003.00465.x
- 30. Ansah O, Raekallio M, Vainio O: Comparison of three doses of
dexmedetomidine with medetomidine in cats following intramuscular
administration. J Vet Pharmacol Ther, 21, 380-387, 1998. DOI: 10.1046/j.
1365-2885.1998.00155.x
- 31. Souza SS, Intelisano TR, De Biaggi CP, Moura CA, Selmi AL, Dias
RA, Cortopassi SRG: Cardiopulmonary and isoflrane‐sparing effcts of
epidural or intravenous infusion of dexmedetomidine in cats undergoing
surgery with epidural lidocaine. Vet Anaesth Analg, 37 (2): 106-115, 2010.
DOI: 10.1111/j.1467-2995.2009.00512.x
- 32. Haskins SC, Patz JD, Farver TB: Xylazine and xylazine-ketamine in
dogs. Am J Vet Res, 47 (3): 636-641, 1986.
- 33. Granholm M, McKusick BC, Westerholm FC, Aspegrén JC:
Evaluation of the clinical efficacy and safety of dexmedetomidine or
medetomidine in cats and their reversal with atipamezole. Vet Anaesth
Analg, 33 (4): 214-223, 2006. DOI: 10.1111/j.1467-2995.2005.00259.x
- 34. Pypendop BH, Verstegen JP: Cardiovascular effcts of romifidine in
dogs. Am J Vet Res, 62 (4): 490-495, 2001. DOI: 10.2460/ajvr.2001.62.490
- 35. Virtanen R: Pharmacological profiles of medetomidine and its
antagonist, atipamezole. Acta Vet Scand Suppl, 85, 29-37, 1989.
- 36. Väisänen M, Raekallio M, Kuusela E, Huttunen P, Leppäluoto
J, Kirves P, Vainio O: Evaluation of the perioperative stress response
in dogs administered medetomidine or acepromazine as part of the
preanesthetic medication. Am J Vet Res, 63 (7): 969-975, 2002. DOI:
10.2460/ajvr.2002.63.969